PMC, the Personalized Medicine Coalition, announced that George Poste, DVM, PhD, Regents Professor and Del E. Webb Chair in Health Innovation and Chief Scientist, Complex Adaptive Systems Initiative at Arizona State University, will receive the 2025 Award for Leadership in Personalized Medicine at this year’s Personalized Medicine Conference, to be held November 13–14 at the Ritz Carlton, Laguna Niguel, in Dana Point, California. This award recognizes Dr. Poste’s substantial multi-decade contributions to the advancement of personalized medicine and his enduring impact on science, technology, and policy.Continue reading
Category Archives: AZBio News
Marvin Slepian recognized with Distinguished Faculty Award
Marvin J. Slepian, MD, JD, a Regents Professor of medicine, radiology and imaging sciences and surgery at the University of Arizona College of Medicine – Tucson and of biomedical engineering at the U of A College of Engineering, received this year’s University Distinguished Innovation and Entrepreneurship Award. Continue reading
NIH researchers develop AI agent that improves accuracy of gene set analysis by leveraging expert-curated databases
Researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) agent powered by a large language model (LLM) that creates more accurate and informative descriptions of biological processes and their functions in gene set analysis than current systems.Continue reading
Study reveals a novel immune-based therapy that may be effective in hard-to-treat lung cancers
Findings suggest that the patients themselves produce molecules that could reawaken their immune system to battle lung cancerContinue reading
Join Global Leaders in Shaping the Future of Drug Development at C-Path’s 2025 Global Impact Conference
Every Stage, Every Step: Transforming Lives Through Optimized Drug DevelopmentContinue reading
Celebrating Suzanne Pfister’s Legacy
Suzanne Pfister, an extraordinary leader and public servant whose tenure as Vitalyst Health Foundation’s President and CEO transformed the organization and inspired paradigm-shifting change across Arizona’s health landscape.
Continue reading
Stanford faculty member George Tidmarsh, M.D., Ph.D. named Director of Center for Drug Evaluation and Research
The U.S. Food and Drug Administration today announced the appointment of George Francis Tidmarsh, M.D., Ph.D., as Director of the Center for Drug Evaluation and Research (CDER). In this role, Dr. Tidmarsh will lead the FDA’s efforts to ensure safe, effective, and high-quality drugs are available to the American people.Continue reading
Critical Path Institute Appoints Dr. Aoife Brennan to Board of Directors
TUCSON, Ariz., July 16, 2025 — Critical Path Institute® (C-Path) today announced the appointment of Aoife Brennan, M.D., to its Board of Directors. Dr. Brennan brings extensive experience in biopharmaceutical leadership, clinical development, and regulatory strategy to C-Path’s growing efforts to advance global drug development and data-driven science.Continue reading
C-Path’s Translational Therapeutics Accelerator Announces $200,000 Grant for Drug Development Project in Inflammatory Bowel Disease
University Hospitals Cleveland Medical Center physician awarded funding to advance novel therapy for IBD.Continue reading
GT Medical Technologies Completes Final Close of Company’s Oversubscribed $53 Million Series D Equity Financing to Advance Commercial Treatment for Patients with Operable Brain Tumors
July 15, 2025 /PRNewswire/ — GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, today announced the company has completed the close of its oversubscribed $53 million Series D equity financing.Continue reading